-
Loading metrics
Sequential Targeting of CD52 and TNF Allows Early Minimization Therapy in Kidney Transplantation: From a Biomarker to Targeting in a Proof-Of-Concept Trial
- Ondrej Viklicky,
- Petra Hruba,
- Stefan Tomiuk,
- Sabrina Schmitz,
- Bernhard Gerstmayer,
- Birgit Sawitzki,
- Patrick Miqueu,
- Petra Mrazova,
- Irena Tycova,
- Eva Svobodova
x
- Published: January 13, 2017
- https://doi.org/10.1371/journal.pone.0169624